Automated Analyzers Market Report 2026

Automated Analyzers Market Overview

• Automated Analyzers market size has reached to $5.39 billion in 2025 • Expected to grow to $7.6 billion in 2030 at a compound annual growth rate (CAGR) of 7% • Growth Driver: Rising Prevalence Of Chronic Diseases Driving Growth In The Automated Analyzers Market • Market Trend: Innovative Advancements In Automated Clinical Chemistry Enhanced Market Growth • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

The key promising market opportunities in the automated analyzers market include: • Immuno-Based Analyzers (Segmentation By Type) → Expected gain of $1274.12 Million • Blood (Segmentation By Sample Type) → Expected gain of $1129.4 Million • Diagnostic Laboratories (Segmentation By End User) → Expected gain of $980.4 Million

What Is Covered Under Automated Analyzers Market?

Automated analyzers are laboratory devices designed to perform repetitive analytical tests with minimal human intervention. They enhance efficiency by processing large volumes of samples accurately and rapidly. These systems are commonly used in clinical, chemical, and hematological analyses. The main types of automated analyzers are biochemistry analyzers, immuno-based analyzers, hematology analyzers, and others. Biochemistry analyzers are laboratory instruments used to measure the concentration of various biochemical substances in biological samples for diagnostic and research purposes. They handle sample types including blood, urine, serum, plasma, and others. These analyzers are used in applications such as drug discovery, genomics, proteomics, bioanalysis, clinical diagnostics, and more, and are utilized by end users such as hospitals and clinics, diagnostic laboratories, pharmaceutical and biotechnology companies, and others.

What Is The Automated Analyzers Market Growth Forecast?

The automated analyzers market size is expected to see strong growth in the next few years. It will grow to $7.6 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to advancement in fully automated analyzers, integration with ai and big data analytics, rising demand for rapid diagnostics, expansion of genomics and proteomics research, adoption of point-of-care testing solutions. Major trends in the forecast period include increasing adoption of automated laboratory systems, rising demand for high-throughput sample processing, integration of multi-functional analyzers in labs, growth in clinical diagnostics and research applications, enhanced accuracy and standardization in analytical testing.

What Is The Driver Of The Automated Analyzers Market?

The rising prevalence of chronic diseases is expected to propel the growth of the automated analyzers market going forward. The prevalence of chronic diseases is rising due to aging populations, unhealthy lifestyles, and increased urbanization globally. Automated analyzers are used in chronic disease management for efficient and accurate diagnostic testing, enabling early detection, monitoring, and treatment of conditions like diabetes, cardiovascular diseases, and kidney disorders. For instance, in June 2023, according to the report published by Kidney Research UK, a UK-based non-profit organization, approximately 7.2 million people in the UK are living with chronic kidney disease, representing over 10% of the population. Of these, 3.25 million are in the advanced stages of the disease, while an additional 3.9 million are in the early stages. By 2033, the number of individuals affected by chronic kidney disease is projected to rise to 7.61 million. Therefore, the rising prevalence of chronic diseases is driving the growth of the automated analyzers industry.

How Will The Drivers Impact Growth In The Global Automated Analyzers Market?

• Increasing Prevalence of Chronic Diseases (Medium) – The increasing emphasis on prevalence of chronic diseases will become a key driver of growth in the automated analyzers market by 2030. The rise in conditions such as diabetes, cardiovascular diseases, and cancer is driving healthcare facilities to adopt advanced diagnostic technologies that can handle high testing volumes with reduced turnaround times. Automated analyzers support clinical decision-making by delivering consistent and precise results, which are critical for the timely management of chronic illnesses. As a result, the growing deployment of prevalence of chronic diseases is anticipated to contributing to a 1.5% annual growth in the market. • Rising Research and Development Activities (Medium) – The growing focus on research and development activities will emerge as a major factor driving the expansion of the automated analyzers market by 2030. Continuous innovation in life sciences, biotechnology, and clinical diagnostics is driving the need for advanced instruments that can support high-throughput testing and deliver faster, more reliable results. Companies are increasingly investing in the development of automated platforms with integrated software, artificial intelligence, and data management solutions to streamline laboratory workflows and reduce operational costs. Consequently, the accelerating adoption of research and development activities capabilities is projected to contributing to a 1.0% annual growth in the market. • Rising Demand for Laboratory Automation (Low) – The expanding integration of demand for laboratory automation processes will serve as a key growth catalyst for the automated analyzers market by 2030. As laboratories face growing sample volumes and increasing pressure to deliver faster and more accurate results, automation has become critical in streamlining operations and minimizing human errors. Automated analyzers enable high-throughput testing, consistent result quality, and improved operational efficiency, making them essential tools in clinical diagnostics, pharmaceutical research, and industrial laboratories. Therefore, this growing integration of demand for laboratory automation operations is projected to supporting to a 1.0% annual growth in the market. • Increase in Clinical Workload (Low) – The increasing emphasis on clinical workload will become a significant driver contributing to the growth of the automated analyzers market by 2030. Growing patient populations, rising incidences of chronic and infectious diseases, and expanded screening programs are contributing to a significant surge in diagnostic testing. This escalating demand is straining laboratory resources and driving healthcare facilities to adopt automated analyzers that can process large numbers of samples efficiently with minimal manual input. Consequently, the rising adoption of clinical workload strategies is projected to contributing to a 0.5% annual growth in the market.

How Will The Restraints Impact Growth In The Global Automated Analyzers Market?

• Lack of Skilled Personnel (Medium) – Lack of Skilled Personnel will restrict the growth of the Automated Analyzers market during the forecast period. Automated analyzers require skilled laboratory professionals for operation, maintenance, and result interpretation. The shortage of qualified laboratory technicians and scientists limits the capacity of healthcare facilities to adopt and utilize automated analyzers. This skill gap can lead to underutilization of equipment, operational challenges, and slower market growth in regions with limited healthcare training infrastructure. • Integration Challenges with Legacy Systems (Medium) – Integration Challenges with Legacy Systems will restrict the growth of the Automated Analyzers market during the forecast period. Integrating new automated analyzers with existing laboratory information systems and workflows presents significant technical challenges. Compatibility issues, data format differences, and the need for system customization can complicate implementation. Integration challenges can increase project costs, extend deployment timelines, and affect the operational efficiency of laboratory automation projects.

Key Players In The Global Automated Analyzers Market

Major companies operating in the automated analyzers market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Honeywell International, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Tosoh Corporation, Agilent Technologies Inc., Grifols S.A., Xylem Inc., Hitachi High-Tech Corporation, Mindray, PerkinElmer Inc, bioMérieux SA, Sysmex Corporation, Bruker Corporation, Horiba Medical, Randox Laboratories Ltd., Nova Biomedical Corporation, Trinity Biotech Plc

Global Automated Analyzers Market Trends and Insights

Major companies operating in the automated analyzers market are focusing on developing innovative solutions such as automated clinical chemistry analyzers to enhance efficiency, accuracy, and throughput in diagnostic laboratories. Automated clinical chemistry analyzers refer to advanced instruments used in laboratories to perform a wide range of chemical tests on blood and other bodily fluids with minimal human intervention, enhancing efficiency and accuracy in diagnostic testing. For instance, in January 2024, Beckman Coulter, a US-based manufacturing company, launched the DxC 500 AU Chemistry Analyzer, which represents a cutting-edge advancement in automated clinical chemistry. Boasting over 120 high-quality assays, this analyzer is engineered to significantly enhance the capabilities of satellite and independent community hospital labs. It integrates sophisticated automation, streamlined workflows, and standardized reagents to boost testing efficiency and aid in clinical decision-making. By serving as a vital complement to central hub laboratories within healthcare systems that utilize hub-and-spoke models, the DxC 500 AU enhances overall efficiency and expands access to essential testing services.

What Are Latest Mergers And Acquisitions In The Automated Analyzers Market?

In April 2024, Valmet, a Finland-based technology company, acquired the process gas chromatography business from Siemens Healthineers AG for $113.05 million. The acquisition aligns with Valmet’s strategy to boost its automation segment and process automation capabilities, especially in gas chromatograph and process analyzer systems. The acquired business will become part of Valmet’s automation systems division under a new unit, analyzer products, and integration, strengthening its position in this field. Siemens Healthineers AG is a Germany-based engineering and manufacturing company that specializes in automated analyzers.

What Defines the Automated Analyzers Market?

The automated analyzers market consists of sales of biochemistry analyzers, hematology analyzers, immunoassay analyzers, blood gas analyzers, and molecular analyzers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Automated Analyzers Market Report 2026?

The automated analyzers market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the automated analyzers industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.